Cargando…

Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells

SIMPLE SUMMARY: Metastasis is the leading cause of death in breast cancer, and it can be predicted by the detection of circulating tumor cells in the blood and disseminated tumor cells in the bone marrow, which are usually detected by epithelial marker proteins. However, tumor cells with mesenchymal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartkowiak, Kai, Heidrich, Isabel, Kwiatkowski, Marcel, Gorges, Tobias M., Andreas, Antje, Geffken, Maria, Verpoort, Karl, Müller, Volkmar, Schlüter, Hartmut, Pantel, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867178/ https://www.ncbi.nlm.nih.gov/pubmed/33540545 http://dx.doi.org/10.3390/cancers13030563

Ejemplares similares

Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
por: Ac\ˇkar, Lucija, et al.
Publicado: (2021)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: JIE, LI-GANG, et al.
Publicado: (2015)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: Jie, Li-Gang, et al.
Publicado: (2022)

Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease
por: Su, Yutong, et al.
Publicado: (2019)

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2018)

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2022)

Dickkopf-1/cysteine-rich angiogenic inducer 61 axis mediates palmitic acid-induced inflammation and apoptosis of vascular endothelial cells
por: Gan, Yi-Rong, et al.
Publicado: (2021)

Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis
por: Fan, Yong, et al.
Publicado: (2019)

In Vitro Modeling of Reoxygenation Effects on mRNA and Protein Levels in Hypoxic Tumor Cells upon Entry into the Bloodstream
por: Bartkowiak, Kai, et al.
Publicado: (2020)

Activating transcription factor 3 inhibits angiotensin II-induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine-rich angiogenic protein 61
por: Zhang, Yu, et al.
Publicado: (2022)

Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer
por: Wang, Yan, et al.
Publicado: (2016)

Critical Role of Cysteine-Rich Protein 61 in Mediating the Activation of Renal Fibroblasts
por: Liu, Hang, et al.
Publicado: (2019)

Cysteine-Rich Protein 61 Plays a Proinflammatory Role in Obstructive Kidney Fibrosis
por: Lai, Chun-Fu, et al.
Publicado: (2013)

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
por: Gao, Lan, et al.
Publicado: (2017)

Cysteine‐Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes
por: Klingenberg, Roland, et al.
Publicado: (2021)

Urinary Cysteine-Rich Protein 61 and Trefoil Factor 3 as Diagnostic Biomarkers for Colorectal Cancer()
por: Shimura, Takaya, et al.
Publicado: (2019)

The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine
por: Bhoopathi, P, et al.
Publicado: (2010)

Study of Cysteine-Rich Protein 61 Genetic Polymorphism in Predisposition to Fracture Nonunion: A Case Control
por: Ali, Sabir, et al.
Publicado: (2015)

Diagnostic value of using exosome-derived cysteine-rich protein 61 as biomarkers for acute coronary syndrome
por: Li, Wei, et al.
Publicado: (2021)

Deubiquitinase ubiquitin‐specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma
por: Liu, Xun, et al.
Publicado: (2022)

Cross-sectional and longitudinal associations of serum Cysteine-rich 61 with severity and prognosis among community-acquired pneumonia patients in China
por: Yao, Meng-Xing, et al.
Publicado: (2022)

Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
por: Heidrich, Isabel, et al.
Publicado: (2022)

Protein Z Exerts Pro-Angiogenic Effects and Upregulates CXCR4
por: Butschkau, Antje, et al.
Publicado: (2014)

Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
por: Zhang, Fengli, et al.
Publicado: (2018)

Pro-angiogenic therapeutics for preeclampsia
por: Eddy, Adrian C., et al.
Publicado: (2018)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Retracted: Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
por: Zhang, Fengli, et al.
Publicado: (2021)

PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma
por: Otani, Yoshihiro, et al.
Publicado: (2017)

Downregulation of Pro-Inflammatory and Pro-Angiogenic Pathways in Prostate Cancer Cells by a Polyphenol-Rich Extract from Olive Mill Wastewater
por: Baci, Denisa, et al.
Publicado: (2019)

Mass spectrometry-based intraoperative tumor diagnostics
por: Hänel, Lorena, et al.
Publicado: (2019)

CYR61—An angiogenic biomarker to early predict the impaired healing in diaphyseal tibial fractures
por: Ali, Sabir, et al.
Publicado: (2017)

Cysteine‐rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl‐2 pathway
por: Song, Yanfang, et al.
Publicado: (2019)

Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors
por: Marek-Trzonkowska, Natalia, et al.
Publicado: (2015)

Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients
por: Riethdorf, Sabine, et al.
Publicado: (2009)

Biology, detection, and clinical implications of circulating tumor cells
por: Joosse, Simon A, et al.
Publicado: (2015)

Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives
por: Müller, Volkmar, et al.
Publicado: (2004)

Oxidant Exposure Induces Cysteine-Rich Protein 61 (CCN1) via c-Jun/AP-1 to Reduce Collagen Expression in Human Dermal Fibroblasts
por: Qin, Zhaoping, et al.
Publicado: (2014)

Associations between urinary cysteine-rich protein 61 excretion and kidney function decline in outpatients with chronic kidney disease: a prospective cohort study in Taiwan
por: Lai, Chun-Fu, et al.
Publicado: (2021)

Control of the Immune Response by Pro-Angiogenic Factors
por: Voron, Thibault, et al.
Publicado: (2014)

Leptin’s Pro-Angiogenic Signature in Breast Cancer
por: Gonzalez-Perez, Ruben Rene, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rgsvmae4mjeufnjb1qspd0js5n